Release Date: 26/03/20 17:10 Summary: OGC Provides Corporate Update In Relation to COVID-19 Price Sensitive: Yes Download Document 88.19KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling